Literature DB >> 11840215

Cytokines and feeding.

C R Plata-Salamán1.   

Abstract

Various categories of cytokines participate in the control of feeding, including interleukin-1 and -6 and other activators of gp 130, leptin (ob protein), interleukin-8 and other chemokines, tumor necrosis factor-alpha, and interferon-alpha. These feeding-inhibitory cytokines may play a role in the regulation of food intake during physiological (eg a role proposed for leptin) and pathophysiological (eg proinflammatory cytokines) conditions. Data show that various cytokines participate in acute and chronic disease-associated anorexia such as during infection, inflammation or malignancy. Food intake suppression (reported as anorexia) is also a common central manifestation observed during cytokine immunotherapy in humans. The concept of local production of various cytokines within specific brain regions in response to peripheral challenges and pathophysiological processes has broad implications for the interpretation of brain cytokines as mediators or participants in CNS modulation of feeding and anorexia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11840215     DOI: 10.1038/sj.ijo.0801911

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  33 in total

1.  Appetite course over time and the risk of death in patients on chronic hemodialysis.

Authors:  Maurizio Bossola; Enrico Di Stasio; Fausto Rosa; Loredana Dominici; Manuela Antocicco; Costanza Pazzaglia; Irene Aprile; Luigi Tazza
Journal:  Int Urol Nephrol       Date:  2012-06-10       Impact factor: 2.370

2.  Side effects of interferon-alpha therapy.

Authors:  Stefan Sleijfer; Marjolein Bannink; Arthur R Van Gool; Wim H J Kruit; Gerrit Stoter
Journal:  Pharm World Sci       Date:  2005-12

3.  Autoantibodies against alpha -MSH, ACTH, and LHRH in anorexia and bulimia nervosa patients.

Authors:  Sergueï O Fetissov; Jarmila Hallman; Lars Oreland; Britt Af Klinteberg; Eva Grenbäck; Anna-Lena Hulting; Tomas Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-16       Impact factor: 11.205

Review 4.  Diet, behavior and immunity across the lifespan.

Authors:  Matthew W Hale; Sarah J Spencer; Bruno Conti; Christine L Jasoni; Stephen Kent; Morgan E Radler; Teresa M Reyes; Luba Sominsky
Journal:  Neurosci Biobehav Rev       Date:  2014-12-15       Impact factor: 8.989

5.  Neuroinflammation in psychiatric disorders: An introductory primer.

Authors:  Geoffrey A Dunn; Jennifer M Loftis; Elinor L Sullivan
Journal:  Pharmacol Biochem Behav       Date:  2020-07-01       Impact factor: 3.533

6.  Central CCL2 signaling onto MCH neurons mediates metabolic and behavioral adaptation to inflammation.

Authors:  Ophélia Le Thuc; Céline Cansell; Miled Bourourou; Raphaël Gp Denis; Katharina Stobbe; Nadège Devaux; Alice Guyon; Julie Cazareth; Catherine Heurteaux; William Rostène; Serge Luquet; Nicolas Blondeau; Jean-Louis Nahon; Carole Rovère
Journal:  EMBO Rep       Date:  2016-10-12       Impact factor: 8.807

Review 7.  Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.

Authors:  Boris Decourt; Debomoy K Lahiri; Marwan N Sabbagh
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

8.  Circulating leptin mediates lipopolysaccharide-induced anorexia and fever in rats.

Authors:  Christelle Sachot; Stephen Poole; Giamal N Luheshi
Journal:  J Physiol       Date:  2004-09-23       Impact factor: 5.182

9.  Genetic and pharmacologic blockade of central melanocortin signaling attenuates cardiac cachexia in rodent models of heart failure.

Authors:  Jarrad M Scarlett; Darren D Bowe; Xinxia Zhu; Ayesha K Batra; Wilmon F Grant; Daniel L Marks
Journal:  J Endocrinol       Date:  2010-04-06       Impact factor: 4.286

10.  Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer.

Authors:  R J E Skipworth; D A C Deans; B H L Tan; K Sangster; S Paterson-Brown; D A Brown; M Hunter; S N Breit; J A Ross; K C H Fearon
Journal:  Br J Cancer       Date:  2010-01-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.